FDA reports issues with certain reworked Philips ventilators

Philips has reported two potential issues with Respironics Trilogy ventilators that were recalled in June 2021 and reworked, last week. The silicone sound abatement foam used to replace the polyester-based polyurethane foam may separate from the plastic backing, potentially blocking the air inlet and lowering inspiratory pressure, FDA said. Philips also found trace amounts of particulate matter in the air pathway of some reworked ventilators. The FDA has requested additional information from Philips to better understand the cause of the issues and inform recommendations, and said it will inform the public as more information becomes available.
Related News Articles
Headline
Despite elegant efforts to design for safe use, rigorous standards and regulatory requirements, and lots of training of health care professionals, there鈥檚鈥
Headline
The Trump administration yesterday announced it issued executive orders authorizing 25% tariffs on all steel and aluminum imports. Importantly, both steel and鈥
Headline
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such as continuous glucose monitors,鈥
Headline
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China. The tariffs for Mexico and Canada have since been delayed鈥
Headline
The Department of Health and Human Services Sept. 30 released a statement on the dockworker strike at ports along the East and Gulf coasts, saying that鈥
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of 鈥渞emanufacturing鈥 for reusable medical devices needing鈥